A Study to Evaluate the Safety of QCZ484 in Healthy and Mild Hypertensive Subjects
- First Posted Date
- 2025-04-01
- Last Posted Date
- 2025-04-01
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 56
- Registration Number
- NCT06905327
- Locations
- 🇳🇿
Novartis Investigative Site, Auckland, New Zealand
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
- First Posted Date
- 2025-03-05
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Novartis Pharmaceuticals
- Target Recruit Count
- 380
- Registration Number
- NCT06857955
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath